Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients
- PMID: 32016908
- DOI: 10.1007/s11255-020-02398-x
Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients
Abstract
Objective: To evaluate the association between basal total testosterone (TT) levels with the European Association of Urology (EAU) risk classes at the time of diagnosis of prostate cancer (PCA).
Methods: A retrospective review of prospectively collected data was carried out between November 2014 and March 2018. Preoperative basal TT levels and PSA were measured in 601 consecutive Caucasian patients who were not under androgen deprivation and undergoing surgery at a tertiary referral center. Patients were classified into low (reference group), intermediate- and high-risk/locally advanced classes. The multinomial logistic regression model evaluated associations of TT and other clinical factors with EAU risk classes.
Results: One hundred twenty four patients (24%) were low risk, 316 (52.6%) were intermediate, 199 (16.5%) were high risk and 42 (7%) were locally advanced. Median circulating basal TT levels increased along EAU classes. TT, PSA, percentage of biopsy-positive cores and tumor clinical stage were independently associated with the high-risk class (odds ratio, OR = 1.002; p = 0.030) but were not associated with intermediate-risk or locally advanced PCA when compared to the low-risk class. TT above the median value was an independent predictor of high-risk class PCA.
Conclusions: Basal TT levels are positively associated with low, intermediate and high EAU risk classes. The association is significant for the high-risk class when compared to the low-risk group, but was lost in locally advanced risk class. In PCA patients, high TT serum levels are associated with high-risk disease. Endogenous TT should be considered as a biological marker for assessing EAU PCA risk classes.
Keywords: EAU risk classes; Prostate cancer; Radical prostatectomy; Total testosterone; Tumor grade group.
Similar articles
-
Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy.Ther Adv Urol. 2020 Jun 24;12:1756287220929481. doi: 10.1177/1756287220929481. eCollection 2020 Jan-Dec. Ther Adv Urol. 2020. PMID: 32636934 Free PMC article.
-
Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk Classes.Urol Int. 2020;104(9-10):716-723. doi: 10.1159/000506525. Epub 2020 May 27. Urol Int. 2020. PMID: 32460298
-
Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer.Urol Int. 2019;103(4):400-407. doi: 10.1159/000500960. Epub 2019 Jun 4. Urol Int. 2019. PMID: 31163438
-
Testosterone and prostate cancer: revisiting old paradigms.Eur Urol. 2009 Jul;56(1):48-56. doi: 10.1016/j.eururo.2009.03.088. Epub 2009 Apr 8. Eur Urol. 2009. PMID: 19375844 Review.
-
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.Eur Urol. 2011 Apr;59(4):572-83. doi: 10.1016/j.eururo.2011.01.025. Epub 2011 Jan 25. Eur Urol. 2011. PMID: 21315502
Cited by
-
Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy.Ther Adv Urol. 2020 Jun 24;12:1756287220929481. doi: 10.1177/1756287220929481. eCollection 2020 Jan-Dec. Ther Adv Urol. 2020. PMID: 32636934 Free PMC article.
-
Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer.Int Urol Nephrol. 2021 Dec;53(12):2517-2526. doi: 10.1007/s11255-021-02990-9. Epub 2021 Sep 27. Int Urol Nephrol. 2021. PMID: 34580803 Free PMC article.
-
Epimedin C enhances mitochondrial energy supply by regulating the interaction between MIC25 and UBC in rodent model.PLoS One. 2025 May 28;20(5):e0325031. doi: 10.1371/journal.pone.0325031. eCollection 2025. PLoS One. 2025. PMID: 40435285 Free PMC article.
-
Investigating the Role of Obesity in Prostate Cancer and Identifying Biomarkers for Drug Discovery: Systems Biology and Deep Learning Approaches.Molecules. 2022 Jan 28;27(3):900. doi: 10.3390/molecules27030900. Molecules. 2022. PMID: 35164166 Free PMC article.
-
Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease.Int Urol Nephrol. 2023 May;55(5):1139-1148. doi: 10.1007/s11255-023-03563-8. Epub 2023 Mar 21. Int Urol Nephrol. 2023. PMID: 36943597
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous